Results 111 to 120 of about 5,020 (198)

Mutations in ACVR1 that result in Fibrodysplasia ossificans progressiva

open access: yes, 2019
Analyzing the various point mutations in the coding of ACVR1 that result in connective tissue disease Fibrodysplasia ossificans progressiva by using various molecular dynamics ...
Weatherby, William
core  

An Activin Receptor IA/Activin-Like Kinase-2 (R206H) Mutation in Fibrodysplasia Ossificans Progressiva

open access: yesCase Reports in Genetics, 2013
Fibrodysplasia ossificans progressiva (FOP) is an exceptionally rare genetic disease that is characterised by congenital malformations of the great toes and progressive heterotopic ossification (HO) in specific anatomical areas. This disease is caused by
Rafael Herrera-Esparza   +7 more
doaj   +1 more source

Molecular Developmental Biology of Fibrodysplasia Ossificans Progressiva: Measuring the Giant by Its Toe

open access: yesBiomolecules
When a genetic disease is characterized by the abnormal activation of normal molecular pathways and cellular events, it is illuminating to critically examine the places and times of these activities both in health and disease.
O. Will Towler   +2 more
doaj   +1 more source

Purification Of Acvr1 Alone And Tgfbr1 (Alk5) Complexed With Fkbp12

open access: yes, 2018
Purifications of ALK2 and ALK5 (the latter in complex with FKBP12) and crystal ...
Adamson, Roslin   +3 more
openaire   +2 more sources

Determining the IC50 values of 30 legacy ACVR1/ALK2 inhibitors

open access: yes, 2018
A large number of ACVR1/ALK2 inhibitors were previously synthesised by Paul Brenner’s team (Target Discovery Center, University of Oxford) for the purpose of treating Fibrodysplasia Ossificans Progressiva (FOP). Although these compounds were not designed
Wong, Jong Fu   +3 more
core   +2 more sources

Another Acvr1 Purification For Fragment Screening And Co-Crystallisation

open access: yes, 2018
A rather unsuccessful purification, but nevertheless, enough for three crystal plates to follow up compound ...
Adamson, Roslin   +3 more
openaire   +1 more source

Momelotinib: Mechanism of action, clinical, and translational science

open access: yesClinical and Translational Science
Myelofibrosis is a chronic myeloproliferative disorder characterized by bone marrow fibrosis, splenomegaly, anemia, and constitutional symptoms, with a median survival of ≈6 years from diagnosis.
Georgios Vlasakakis   +8 more
doaj   +1 more source

ACVR1 Allele-Specific Antisense Oligonucleotides

open access: yes
IPFS: QmNPT5Mzt9mwnFUreNhNsjjm4fECQT9Xjf5MNyAgT5pDMi. TX: 0xc6ffa10bd0cd44e5c98d54fe485efc5d46a4aaf1936f8bec57c4ea97a478c0b9. CC0.
openaire   +1 more source

Imatinib Repurposing for ACVR1 Downstream Signaling Inhibition

open access: yes
IPFS: QmQp88cmTnfSNBeTvggvrqUSDn52KZcMXnUUUG6GwoJWNV. TX: 0x5d6e87921cd14d0ed369673eb4b9420a0b8f22cebd7cb561052d47a78accde68. CC0.
openaire   +1 more source

Home - About - Disclaimer - Privacy